12th December 2017, 12.00 - 13.00 CET Due to unforeseen circumstances this webinar has been cancelled and will be rescheduled at a later date.
25 Oct 2017 8:00 AM – 26 Oct 2017 3:30 PM CET Radisson Blu Steinentorstrasse 25 4001 Basel Switzerland
18th October 2017, 15.15-16.15 CET Adaptive Pathways (or Medicine Adaptive Pathways to Patients (MAPPs)) potentially provide a tool to place new, innovative medicines into the market for those patients at greatest unmet need. This webinar will discuss how Eastern European countries are implementing Real World Data tools that can be used to provide the data infrastructure needed to make Adaptive Pathways work.
19th April 2017, 14-15h CET The first public webinar of ADAPT SMART will highlight how consortia members are collaborating with key stakeholder groups to incorporate their feedback into the project's deliverables during the calendar year of 2017.
18th January 2017 London, United Kingdom On the 18th of Janaury, ADAPT SMART hosted it’s Annual Meetings and General Assembly at the EMA in London.
8th December 2016 London, United Kingdom On the 8th of December 2016, the European Medicines Agency has organised a workshop in collaboration with the European Commission to gather the views and proposals from stakeholders on the adaptive pathways approach.
ADAPT SMART Workshop: “Seamless pathway and the impact on decision making: Exploring and aligning stakeholder needs”
6th July 2016
London, United Kingdom
On the 6th of July 2016 ADAPT SMART organised a one day workshops entitled "The Seamless pathway and the impact on decision making: Exploring and aligning stakeholder needs”. More than 30 representatives including; European regulators, Health Technology Assessment (HTA) bodies, the pharmaceutical industry, patient organizations, health care professionals and academics attended the workshop.
5th July 2016
London, United Kingdom
On the 5th of July 2016 ADAPT SMART organised a one day workshops entitled "Managed entry in the context of adaptive pathways.” The workshop was held in London and around 30 attendees represented key European stakeholder groups: health technology assessment (HTA) bodies, payer organisations, or manufacturers.
On 27th October, thought leaders in the field of adaptive pathways met in Washington D.C. to discuss the global objectives of IMI ADAPT SMART and what the landmark project hopes to achieve.